Extract from M&A Insights

The below story was originally featured in our daily M&A Insights Newsletter. Selected stories, including this one, are posted to our website with some weeks of delay.
CELLINK acquires German-based Dispendix for EUR 5m
November 30, 2018

CELLINK has acquired the German-based biodispensing company dispendix for EUR 5m. Dispendix operates within the Life Science industry and focuses on biodispensing technology. Their technologies enable faster tests in drug development. Dispendix has one patented technology, I-DOT. Dispendix expects a net sales of SEK 16m in 2018, corresponding to a pro-forma EV/Sales multiple of 3.2x.

ⓘ This story was originally featured in our daily M&A Insights newsletter.
Our insights have been covered by: